International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2015 - Volume 19, Number 6
View All Articles in Issue

Page(s): 504

Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, acetominophen, codeine phosphate, moderate pain, pain relief, analgesic, analgesia, drug shortage

Related Categories: FORMULATIONS, PAIN MANAGEMENT

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules Allen Loyd V Jr	Nov/Dec 2015 Pg. 504
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Codeine Phosphate 3 mg/mL in Ora-Sweet Allen Loyd V Jr	Mar/Apr 2022 Pg. 141
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Aspirin 380-mg, Caffeine 30-mg, and Codeine Phosphate 30-mg Capsules Allen Loyd V Jr	Sep/Oct 2005 Pg. 388
Acetaminophen 400-mg, Aspirin 250-mg, Codeine Phosphate 30-mg with Antacids Capsules Allen Loyd V Jr	Sep/Oct 2005 Pg. 386
Acetaminophen 325-mg, Codeine Phosphate 32.5-mg, and Phenyltoloxamine Citrate 30-mg Capsules Allen Loyd V Jr	Sep/Oct 2005 Pg. 387
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Mar/Apr 2024 Pg. 100-109
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L	May/Jun 2010 Pg. 200-203
Triprolidine HCl 1.25-mg/5-mL, Pseudoephedrine HCl 30-mg/5-mL and Codeine Phosphate 10-mg/5-mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2003 Pg. 304
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jul/Aug 2015 Pg. 295-300
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Mar/Apr 2024 Pg. 111-116
Isoniazid 300-mg Capsules Allen Loyd V Jr	May/Jun 2013 Pg. 232
Aspirin 325-mg, Codeine Phosphate 30-mg, Aluminum Glycinate 48.6-mg, and Magnesium Carbonate 97.2-mg Capsules Allen Loyd V Jr	Sep/Oct 2005 Pg. 389
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen Zugerman Jessie Jean M, Reed Thomas C	Nov/Dec 2007 Pg. 514-519
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Allen Loyd V Jr	Nov/Dec 2015 Pg. 508
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Rabi Joseph	Mar/Apr 2016 Pg. 107-113
Return to Top